Dyne Therapeutics Reports First Quarter 2024 Financial Resul

- Additional Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Anticipated in the Second Half of 2024 - WALTHAM, Mass., May 02, 2024 -- Dyne Therapeutics,...

Related Keywords

United States , American , Stacy Nartker , John Cox , Amy Reilly , Linkedin , Dyne Therapeutics Inc , Nasdaq , Exchange Commission , Muscular Dystrophy Association , Facebook , American Academy Of Neurology , Clinical Data , Second Half , Scientific Conference , American Academy , Private Securities Litigation Reform Act , Consolidated Statement , Months Ended March , Consolidated Balance Sheet Data , Markets ,